To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene CCNB2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
456 supporting clones for gene CCNB2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BP267346 thyroid .a 1 to 582 1 to 581   tiling clone,   581/581
(100 %)
1 diff
(99.9 %id)
BP267770 thyroid .a 1 to 582 1 to 580       580/580
(100 %)
2 diff
(99.7 %id)
BU934242 mixed (pool of 40 RNAs) .a 7 to 747 1 to 756       754/854
(88 %)
32 diff
(96.3 %id)
CN281363 embryonic stem cells, DMSO-treated H9 cellline .a 16 to 629 1 to 612   tiling clone,   612/612
(100 %)
1 diff
(99.9 %id)
CR608686 Neuroblastoma Cot 25-normalized .a 18 to 1518 1 to 1501 exact     1501/1501
(100 %)
0 diff
(100 %id)
BX375984 Neuroblastoma Cot 25-normalized .a 18 to 724 1 to 706   fully sequenced,   706/706
(100 %)
1 diff
(99.9 %id)
DB047645 testis .a 18 to 573 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DB031965 testis .a 26 to 591 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
CX752183 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 27 to 782 1 to 749     Submitted on the opposite strand 749/836
(89 %)
7 diff
(99.2 %id)
BG720151 testis .a 34 to 679 1 to 646       646/646
(100 %)
4 diff
(99.4 %id)
BM835720 stomach .a 34 to 590 1 to 556       556/556
(100 %)
2 diff
(99.7 %id)
BF212191 bone marrow, from chronic myelogenous leukemia .a 35 to 620 1 to 585       585/585
(100 %)
4 diff
(99.4 %id)
BP224506   .a 36 to 622 1 to 588       588/588
(100 %)
1 diff
(99.9 %id)
DB444497 testis .a 36 to 477 1 to 445       445/445
(100 %)
24 diff
(94.7 %id)
DB448436 testis .a 36 to 449 1 to 422       422/422
(100 %)
9 diff
(97.9 %id)
DB452938 testis .a 36 to 536 1 to 501       501/501
(100 %)
1 diff
(99.9 %id)
BP252129 Kidney .a 37 to 618 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BP255394 Kidney .a 37 to 617 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
DA614183   .a 37 to 618 2 to 584   capped   583/583
(100 %)
2 diff
(99.7 %id)
BM788644 stomach .a 37 to 542 1 to 506       506/506
(100 %)
0 diff
(100 %id)
DA905918   .a 37 to 600 2 to 567   capped   566/566
(100 %)
4 diff
(99.3 %id)
BP353299   .a 37 to 617 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BP356181   .a 37 to 619 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
DB128988 thymus .a 37 to 589 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DB143839 thymus .a 37 to 596 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
BP369266 testis .a 37 to 617 1 to 581       581/581
(100 %)
0 diff
(100 %id)
DA000588   .a 38 to 551 2 to 515   capped   514/514
(100 %)
0 diff
(100 %id)
DA002311   .a 38 to 612 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DA614765   .a 38 to 611 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
BP354963   .a 38 to 616 1 to 581       581/582
(99 %)
14 diff
(97.6 %id)
DB105042 thymus .a 38 to 596 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DB145540 thymus .a 38 to 508 2 to 472   capped   471/471
(100 %)
0 diff
(100 %id)
BP383479   .a 38 to 536 1 to 499       499/499
(100 %)
6 diff
(98.8 %id)
BP225118   .a 39 to 623 1 to 585       585/585
(100 %)
0 diff
(100 %id)
CB129822 Liver .a 39 to 535 1 to 497       497/497
(100 %)
0 diff
(100 %id)
BM773104 Ascites, stomach .a 39 to 554 1 to 515       515/515
(100 %)
1 diff
(99.9 %id)
DA915455   .a 39 to 586 2 to 549   capped   548/548
(100 %)
2 diff
(99.7 %id)
BP352367   .a 39 to 620 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DA004436   .a 40 to 602 12 to 574   capped   563/573
(98 %)
0 diff
(100 %id)
DA005881   .a 40 to 478 2 to 440   capped   439/439
(100 %)
0 diff
(100 %id)
DA608180   .a 40 to 595 2 to 555   capped   554/554
(100 %)
1 diff
(99.9 %id)
DA610328   .a 40 to 601 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DB121497 thymus .a 40 to 591 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
BG469013 adenocarcinoma cell line, colon .a 42 to 804 1 to 765       765/766
(99 %)
7 diff
(99.1 %id)
BM553940 brain, medulla .a 42 to 1026 1 to 993       993/1018
(97 %)
21 diff
(98.0 %id)
BY995348   .a 43 to 742 7 to 705       699/705
(99 %)
6 diff
(99.2 %id)
BP320473 placenta .a 43 to 623 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
AK001404   .a 44 to 1550 1 to 1507 exact available from FLJ,   1507/1507
(100 %)
0 diff
(100 %id)
DA429695 colon .a 44 to 591 2 to 550   capped   549/549
(100 %)
1 diff
(99.9 %id)
NM_004701.2   .a 44 to 1555 1 to 1512 exact RefSeq, AAA   1512/1512
(100 %)
1 diff
(100.0 %id)
CD687347 normal nasopharynx .a 45 to 665 37 to 657       621/657
(94 %)
6 diff
(99.1 %id)
AU127488   .a 45 to 568 2 to 525   capped   524/524
(100 %)
3 diff
(99.5 %id)
BP354714   .a 45 to 627 1 to 581       581/582
(99 %)
4 diff
(99.4 %id)
BM852959 Ascites, stomach .a 48 to 541 1 to 494       494/494
(100 %)
0 diff
(100 %id)
CD619174   .a 50 to 752 713 to 10       704/720
(97 %)
4 diff
(99.5 %id)
CD619175   .a 50 to 662 8 to 622       615/622
(98 %)
10 diff
(98.4 %id)
BQ053946 blood, natural killer cells, cell line .a 50 to 939 1 to 901       901/1110
(81 %)
9 diff
(99.2 %id)
CF122959 CNCAP(3)T-225 cell line, Prostate .a 50 to 550 8 to 507       500/507
(98 %)
8 diff
(98.5 %id)
CF123371 CNCAP(3)T-225 cell line, Prostate .a 50 to 715 8 to 671       664/671
(98 %)
8 diff
(98.9 %id)
TI_154182695   .a 50 to 711 67 to 723       655/841
(77 %)
21 diff
(97.6 %id)
TI_154183310   .a 50 to 840 69 to 846       778/780
(99 %)
20 diff
(97.5 %id)
CN281379 embryonic stem cells, cell lines H1, H7, andH9 .a 52 to 788 1 to 739       739/739
(100 %)
3 diff
(99.6 %id)
CN281376 embryonic stem cells, cell lines H1, H7, andH9 .a 53 to 699 1 to 647       647/647
(100 %)
2 diff
(99.7 %id)
CN281378 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 53 to 498 18 to 463       446/463
(96 %)
6 diff
(98.8 %id)
BG717234 testis .a 53 to 839 1 to 788       788/788
(100 %)
8 diff
(99.0 %id)
BI116315 lung, small cell carcinoma .a 53 to 1032 1 to 993       995/1166
(85 %)
53 diff
(95.5 %id)
DA612287   .a 53 to 596 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
BM455332 lymph, lymphoma, cell line .a 54 to 1023 1 to 973       973/1023
(95 %)
18 diff
(98.3 %id)
BM455350 lymph, lymphoma, cell line .a 54 to 983 1 to 934       934/1047
(89 %)
37 diff
(96.5 %id)
CX755117 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 54 to 767 1 to 709     Submitted on the opposite strand 709/833
(85 %)
9 diff
(99.0 %id)
AL080146 testis .a 55 to 1550 1 to 1496 exact available from DKFZ, AAA   1496/1496
(100 %)
1 diff
(100.0 %id)
DB452429 testis .a 55 to 533 1 to 479       479/479
(100 %)
1 diff
(99.8 %id)
BU176998 melanotic melanoma, skin .a 55 to 924 1 to 884       884/890
(99 %)
23 diff
(97.5 %id)
DN601848 human embryonic stem cells .a 55 to 776 1 to 722       722/722
(100 %)
1 diff
(99.9 %id)
DA613382   .a 56 to 632 2 to 581   capped   580/580
(100 %)
4 diff
(99.4 %id)
DB028025 testis .a 56 to 379 2 to 325   capped   324/324
(100 %)
0 diff
(100 %id)
BG943931 blood .a 57 to 506 1 to 450       450/450
(100 %)
2 diff
(99.6 %id)
BG385643 adenocarcinoma cell line, colon .a 57 to 704 1 to 646       646/650
(99 %)
6 diff
(99.1 %id)
BG575960 breast, mammary adenocarcinoma, cell line .a 57 to 674 16 to 631       616/631
(97 %)
10 diff
(98.5 %id)
BI766080 pooled lung and spleen .a 57 to 805 1 to 748       750/748
(100 %)
9 diff
(98.8 %id)
BQ424199 eye, retinoblastoma .a 57 to 889 23 to 861       839/861
(97 %)
16 diff
(98.2 %id)
TI_57177999   .a 57 to 805 34 to 781       750/781
(96 %)
13 diff
(98.4 %id)
BI862807 breast, mammary adenocarcinoma, cell line .a 58 to 575 27 to 544       518/544
(95 %)
6 diff
(98.9 %id)
BM048887 carcinoma, cell line, Prostate .a 58 to 663 1 to 608       608/608
(100 %)
11 diff
(98.2 %id)
TI_57191950   .a 58 to 575 27 to 544       518/544
(95 %)
6 diff
(98.9 %id)
AU143015   .a 59 to 917 2 to 863   capped   862/866
(99 %)
11 diff
(98.8 %id)
BC105086 Brain, cerebral cortex, PCR rescued clones .a 60 to 1420 1 to 1361 exact     1361/1361
(100 %)
0 diff
(100 %id)
BC105112 Brain, cerebral cortex, PCR rescued clones .a 60 to 1420 1 to 1361 exact     1361/1361
(100 %)
0 diff
(100 %id)
TI_1241112209   .a 60 to 1081 1031 to 10       1022/1248
(81 %)
0 diff
(100 %id)
TI_1241112217   .a 60 to 568 509 to 1       509/1253
(40 %)
1 diff
(100.0 %id)
DA432094 colon .a 60 to 577 2 to 519   capped   518/518
(100 %)
0 diff
(100 %id)
AW408459 lymph .a 60 to 593 1 to 534       534/534
(100 %)
4 diff
(99.3 %id)
BG248650 adenocarcinoma cell line, colon .a 61 to 889 1 to 820       820/968
(84 %)
19 diff
(98.1 %id)
BU543842 carcinoma, cell line, Prostate .a 61 to 917 1 to 863       863/864
(99 %)
9 diff
(99.0 %id)
BP369064 testis .a 61 to 629 1 to 570       570/570
(100 %)
4 diff
(99.3 %id)
CN281380 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 62 to 762 1 to 701       701/701
(100 %)
0 diff
(100 %id)
BG681291 skin, squamous cell carcinoma .a 62 to 882 1 to 822       822/822
(100 %)
3 diff
(99.7 %id)
CA487455   .a 62 to 1011 1 to 949       949/949
(100 %)
11 diff
(98.9 %id)
BY799551 eye .a 63 to 667 1 to 605       605/605
(100 %)
0 diff
(100 %id)
TI_44350461   .a 63 to 726 126 to 798       671/798
(84 %)
42 diff
(94.8 %id)
BI561692 testis .a 64 to 726 1 to 673       671/673
(99 %)
41 diff
(94.0 %id)
BQ065301 lymph, lymphoma, cell line .a 64 to 976 1 to 919       919/983
(93 %)
23 diff
(97.7 %id)
AU143555   .a 64 to 918 2 to 858   capped   857/859
(99 %)
16 diff
(98.2 %id)
AF087910   .a 65 to 1555 1 to 1490 S204F L218W E224K T242P AAA   1490/1490
(100 %)
9 diff
(99.4 %id)
R09948 liver and spleen .a 65 to 450 1 to 395       395/451
(87 %)
19 diff
(95.8 %id)
CN281383 embryonic stem cells, DMSO-treated H9 cellline .a 66 to 785 1 to 720       720/720
(100 %)
1 diff
(99.9 %id)
BI830130 brain, medulla .a 66 to 759 1 to 691       691/691
(100 %)
4 diff
(99.5 %id)
BM554412 brain, medulla .a 66 to 1083 21 to 1039       1019/1039
(98 %)
14 diff
(98.7 %id)
TI_57170823   .a 66 to 759 30 to 720       691/720
(95 %)
6 diff
(99.2 %id)
CB132966 Liver .a 66 to 729 1 to 664       664/664
(100 %)
1 diff
(99.9 %id)
TI_154148120   .a 66 to 734 85 to 753       669/669
(100 %)
4 diff
(99.5 %id)
BP366799 thymus .a 66 to 646 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
BP369272 testis .a 66 to 646 1 to 581       581/581
(100 %)
0 diff
(100 %id)
CN281371 embryonic stem cells, DMSO-treated H9 cellline .a 67 to 740 1 to 674       674/674
(100 %)
5 diff
(99.3 %id)
FN132623 breast carcinoma .a 67 to 144 1 to 74       74/83
(89 %)
8 diff
(90.4 %id)
BM819319 stomach .a 67 to 625 1 to 558       558/558
(100 %)
3 diff
(99.5 %id)
BP371057 testis .a 67 to 653 1 to 587       587/587
(100 %)
2 diff
(99.7 %id)
AA308006 colon .a 68 to 439 1 to 371       371/371
(100 %)
1 diff
(99.8 %id)
BG505969 embryonal carcinoma, testis .a 68 to 859 1 to 795       795/795
(100 %)
19 diff
(97.7 %id)
BG530485 embryonal carcinoma, testis .a 68 to 789 1 to 727       725/806
(89 %)
12 diff
(98.6 %id)
BP271873   .a 68 to 646 1 to 579       579/579
(100 %)
5 diff
(99.2 %id)
BM847979 myeloma .a 68 to 644 1 to 576       576/576
(100 %)
3 diff
(99.5 %id)
DB040887 testis .a 68 to 618 2 to 552   capped   551/551
(100 %)
2 diff
(99.7 %id)
AA311856   .a 69 to 492 1 to 423       423/423
(100 %)
3 diff
(99.3 %id)
BU662567 blood .a 69 to 731 11 to 673       663/673
(98 %)
7 diff
(99.0 %id)
BP224727   .a 69 to 649 1 to 581       579/581
(99 %)
8 diff
(98.7 %id)
BX474429   .a 69 to 627 12 to 572       561/572
(98 %)
8 diff
(98.7 %id)
DN915403   .a 69 to 629 1 to 560       560/560
(100 %)
1 diff
(99.9 %id)
DN918495   .a 69 to 741 1 to 673       673/673
(100 %)
2 diff
(99.8 %id)
BG719723 testis .a 69 to 996 6 to 929       926/953
(97 %)
40 diff
(95.9 %id)
CB107210 Liver .a 69 to 527 1 to 459       459/459
(100 %)
0 diff
(100 %id)
BM829044 Ascites, stomach .a 69 to 299 1 to 231       231/231
(100 %)
0 diff
(100 %id)
BM755373 stomach .a 69 to 623 1 to 554       554/554
(100 %)
1 diff
(99.9 %id)
BM847146 myeloma .a 69 to 631 1 to 563       563/563
(100 %)
0 diff
(100 %id)
BP351245   .a 69 to 651 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BP354047   .a 69 to 650 1 to 583       581/583
(99 %)
6 diff
(99.0 %id)
BP354980   .a 69 to 662 1 to 598       599/598
(100 %)
10 diff
(98.4 %id)
BP355547   .a 69 to 649 1 to 582       582/582
(100 %)
5 diff
(99.2 %id)
BP356381   .a 69 to 648 1 to 582       580/582
(99 %)
5 diff
(99.2 %id)
BP368930 testis .a 69 to 644 1 to 572       572/572
(100 %)
5 diff
(99.2 %id)
BP371349 testis .a 69 to 650 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
DA003937   .a 70 to 645 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA004282   .a 70 to 645 2 to 578   capped   577/577
(100 %)
1 diff
(99.9 %id)
AA314336 colon .a 70 to 511 1 to 442       442/442
(100 %)
2 diff
(99.6 %id)
BU658355 blood .a 70 to 461 1 to 392       392/392
(100 %)
1 diff
(99.8 %id)
DA511064 brain .a 70 to 632 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DB459486 testis .a 70 to 551 1 to 482       482/482
(100 %)
0 diff
(100 %id)
DA603849   .a 70 to 579 2 to 511   capped   510/510
(100 %)
0 diff
(100 %id)
DA606341   .a 70 to 625 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DA608320   .a 70 to 637 2 to 569   capped   568/568
(100 %)
2 diff
(99.7 %id)
DA613963   .a 70 to 646 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DA618359   .a 70 to 669 2 to 601   capped   600/600
(100 %)
2 diff
(99.7 %id)
BP283554 bone marrow .a 70 to 651 1 to 583       581/583
(99 %)
1 diff
(99.9 %id)
DA829897 placenta .a 70 to 930 2 to 879   capped   878/949
(92 %)
14 diff
(98.6 %id)
DA911044   .a 70 to 610 2 to 542   capped   541/541
(100 %)
2 diff
(99.7 %id)
BP352887   .a 70 to 651 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
DB018089 esophageal, tumor tissue .a 70 to 629 2 to 562   capped   561/561
(100 %)
3 diff
(99.5 %id)
DB135711 thymus .a 70 to 631 2 to 563   capped   562/563
(99 %)
2 diff
(99.7 %id)
DB152966 thymus .a 70 to 632 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA782485 brain .a 71 to 629 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
CR608927 fetal brain .a 72 to 1502 1 to 1431 exact     1431/1431
(100 %)
0 diff
(100 %id)
AL533824 brain, fetal brain .a 72 to 819 1 to 746   fully sequenced,   746/746
(100 %)
1 diff
(99.9 %id)
BG481125 choriocarcinoma, placenta .a 72 to 951 1 to 873       873/873
(100 %)
27 diff
(97.0 %id)
AA171604   .a 73 to 508 1 to 438       438/438
(100 %)
7 diff
(98.5 %id)
BE793717 lung, small cell carcinoma .a 73 to 736 1 to 663       663/664
(99 %)
1 diff
(99.9 %id)
BE778125 eye, retinoblastoma .a 74 to 763 1 to 689       689/969
(71 %)
7 diff
(99.3 %id)
BE790905 lung, small cell carcinoma .a 74 to 906 1 to 828       828/894
(92 %)
22 diff
(97.6 %id)
AK222611 coronary artery .a 75 to 1555 1 to 1481 K258R AAA   1481/1481
(100 %)
1 diff
(100.0 %id)
BP207140 coronary artery .a 75 to 655 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BG760158 B-cells, primary B-cells from tonsils (cell line) .a 75 to 830 1 to 760       760/760
(100 %)
10 diff
(98.7 %id)
CN281382 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 77 to 788 1 to 714       714/714
(100 %)
7 diff
(99.1 %id)
TI_57172079   .a 77 to 936 65 to 910       848/911
(93 %)
21 diff
(97.7 %id)
BP271722   .a 77 to 679 1 to 603       603/608
(99 %)
14 diff
(97.7 %id)
CN281377 embryonic stem cells, cell lines H1, H7, andH9 .a 78 to 855 1 to 779       777/779
(99 %)
4 diff
(99.5 %id)
AW245692 lung, small cell carcinoma .a 78 to 625 10 to 557       548/557
(98 %)
6 diff
(99.0 %id)
BI831333 brain, medulla .a 78 to 936 1 to 846       848/847
(100 %)
27 diff
(96.9 %id)
BQ223737 melanotic melanoma, skin .a 78 to 967 12 to 907       896/907
(98 %)
26 diff
(97.2 %id)
BG761038 melanotic melanoma, high MDR (cell line), skin .a 79 to 1031 1 to 950       950/975
(97 %)
31 diff
(96.9 %id)
BM012220 brain, neuroblastoma, cell line .a 79 to 999 1 to 933       933/937
(99 %)
43 diff
(95.5 %id)
BP368838 testis .a 79 to 656 1 to 578       578/578
(100 %)
0 diff
(100 %id)
CN281384 embryonic stem cells, cell lines H1, H7, andH9 .a 80 to 601 1 to 522       522/522
(100 %)
3 diff
(99.5 %id)
CR607796 Placenta Cot 25-normalized .a 80 to 1531 1 to 1452 exact     1452/1452
(100 %)
0 diff
(100 %id)
AL550817 placenta, Placenta Cot 25-normalized .a 80 to 1027 1 to 944       944/950
(99 %)
11 diff
(98.9 %id)
BX402578 Placenta Cot 25-normalized .a 80 to 1003 1 to 910       910/930
(97 %)
43 diff
(95.4 %id)
BE778395 eye, retinoblastoma .a 80 to 790 1 to 713       713/878
(81 %)
18 diff
(98.0 %id)
TI_59381422   .a 80 to 999 99 to 1030       932/936
(99 %)
42 diff
(95.6 %id)
DB042570 testis .a 80 to 626 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
TI_154186142   .a 80 to 790 121 to 830       710/939
(75 %)
5 diff
(99.5 %id)
BE255449 eye, retinoblastoma .a 81 to 687 1 to 609       609/609
(100 %)
5 diff
(99.2 %id)
BE745697 adenocarcinoma cell line, ovary .a 81 to 837 1 to 745       747/989
(75 %)
13 diff
(98.7 %id)
BM796647 Ascites, stomach .a 81 to 458 1 to 377       377/377
(100 %)
2 diff
(99.5 %id)
BG328338 adenocarcinoma cell line, colon .a 82 to 792 1 to 702       700/942
(74 %)
17 diff
(98.2 %id)
BE795037 lung, small cell carcinoma .a 84 to 670 1 to 588       588/588
(100 %)
2 diff
(99.7 %id)
BG257068 embryonal carcinoma, cell line, testis .a 85 to 843 1 to 764       764/1203
(63 %)
24 diff
(98.1 %id)
BU173062 eye, retinoblastoma .a 86 to 946 1 to 878       878/925
(94 %)
25 diff
(97.3 %id)
CA487704   .a 86 to 942 1 to 869       869/882
(98 %)
14 diff
(98.5 %id)
BE736413 adenocarcinoma, Pancreas .a 87 to 659 1 to 573       573/573
(100 %)
2 diff
(99.7 %id)
BG755395 B-cells, primary B-cells from tonsils (cell line) .a 87 to 834 1 to 749       749/752
(99 %)
2 diff
(99.8 %id)
CN281374 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 88 to 446 1 to 359       359/359
(100 %)
3 diff
(99.2 %id)
BE886698 leiomyosarcoma, uterus .a 89 to 675 1 to 587       587/589
(99 %)
5 diff
(99.2 %id)
BQ057713 lymph, lymphoma, cell line .a 89 to 770 1 to 691       691/1268
(54 %)
12 diff
(99.1 %id)
CR606395 Neuroblastoma Cot 25-normalized .a 90 to 1519 1 to 1430 exact     1430/1430
(100 %)
0 diff
(100 %id)
BX354143 Neuroblastoma Cot 25-normalized .a 90 to 819 1 to 730   fully sequenced,   730/730
(100 %)
0 diff
(100 %id)
BQ423642 melanotic melanoma, skin .a 90 to 951 1 to 865       865/865
(100 %)
3 diff
(99.7 %id)
BI261204 cervical carcinoma cell line, cervix .a 92 to 785 54 to 755       702/788
(89 %)
28 diff
(96.5 %id)
BX482405   .a 95 to 517 1 to 423       423/423
(100 %)
1 diff
(99.8 %id)
BP268475 thyroid .a 96 to 648 1 to 553       553/553
(100 %)
6 diff
(99.0 %id)
BP268945 thyroid .a 96 to 673 1 to 578       578/578
(100 %)
3 diff
(99.5 %id)
BP268946 thyroid .a 96 to 673 1 to 577       577/577
(100 %)
4 diff
(99.4 %id)
AA333688   .a 97 to 365 1 to 269       269/269
(100 %)
1 diff
(99.7 %id)
CN281364 embryonic stem cells, DMSO-treated H9 cellline .a 98 to 686 1 to 589       589/589
(100 %)
0 diff
(100 %id)
DA006256   .a 101 to 651 2 to 553   capped   552/552
(100 %)
2 diff
(99.7 %id)
BF242551 bone marrow, from acute myelogenous leukemia .a 101 to 778 1 to 683       679/834
(81 %)
72 diff
(91.4 %id)
TI_154185869   .a 103 to 999 113 to 1002       890/990
(89 %)
17 diff
(98.3 %id)
BE263965 lung, small cell carcinoma .a 107 to 763 1 to 653       653/688
(94 %)
12 diff
(98.3 %id)
BE792551 lung, small cell carcinoma .a 107 to 839 1 to 733       735/733
(100 %)
6 diff
(99.2 %id)
BE273256 Kidney, renal cell adenocarcinoma .a 108 to 691 1 to 581       581/581
(100 %)
4 diff
(99.4 %id)
BI260047 cervical carcinoma cell line, cervix .a 109 to 935 1 to 840       840/841
(99 %)
36 diff
(95.8 %id)
CN281366 embryonic stem cells, DMSO-treated H9 cellline .a 110 to 820 8 to 719       712/719
(99 %)
11 diff
(98.5 %id)
CN281381 embryonic stem cells, DMSO-treated H9 cellline .a 110 to 608 1 to 499       499/499
(100 %)
0 diff
(100 %id)
BX337662 Placenta Cot 25-normalized .a 110 to 1093 1 to 984       984/984
(100 %)
32 diff
(96.8 %id)
BM464310 leiomyosarcoma, uterus .a 110 to 1023 20 to 933       914/1136
(80 %)
19 diff
(98.4 %id)
N86231   .a 110 to 427 1 to 319       319/319
(100 %)
4 diff
(98.8 %id)
DR760873 embryonic stem .a 111 to 864 1 to 753       753/753
(100 %)
1 diff
(99.9 %id)
BM015796 breast, mammary adenocarcinoma, cell line .a 114 to 938 1 to 827       827/827
(100 %)
12 diff
(98.6 %id)
TI_59394066   .a 114 to 938 85 to 911       827/827
(100 %)
12 diff
(98.6 %id)
BP370603 testis .a 114 to 684 1 to 571       571/571
(100 %)
3 diff
(99.5 %id)
AA131058.
matches multiple genes
colon, tumor .a 115 to 578 1 to 480     also hits gene soyrarby 480/481
(99 %)
25 diff
(94.9 %id)
BG473111 eye, retinoblastoma .a 116 to 838 1 to 723       723/723
(100 %)
3 diff
(99.6 %id)
W21555 lung .a 117 to 374 1 to 257       257/263
(97 %)
2 diff
(99.3 %id)
BE731990 choriocarcinoma, placenta .a 117 to 773 1 to 655       655/655
(100 %)
4 diff
(99.4 %id)
DR002516 fetal brain .a 117 to 876 8 to 766       759/769
(98 %)
9 diff
(98.9 %id)
BE902569 choriocarcinoma, placenta .a 118 to 790 1 to 670       670/963
(69 %)
8 diff
(99.2 %id)
CN281367 embryonic stem cells, cell lines H1, H7, andH9 .a 120 to 856 13 to 750       738/750
(98 %)
7 diff
(99.1 %id)
BE737630 brain, glioblastoma .a 120 to 786 1 to 662       662/853
(77 %)
15 diff
(98.3 %id)
CD558037 testis .a 120 to 570 1 to 458       458/848
(54 %)
8 diff
(99.1 %id)
BG761581 melanotic melanoma, high MDR (cell line), skin .a 121 to 715 1 to 595       595/595
(100 %)
0 diff
(100 %id)
AB020981   .a 123 to 1555 1 to 1433 exact tiling clone,   1433/1433
(100 %)
0 diff
(100 %id)
CV813319 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 123 to 895 1 to 773       773/773
(100 %)
0 diff
(100 %id)
CN281370 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 128 to 851 1 to 725       725/725
(100 %)
3 diff
(99.6 %id)
BE888966 leiomyosarcoma, uterus .a 129 to 605 1 to 477       477/477
(100 %)
0 diff
(100 %id)
CX873350 embryonic stem .a 129 to 992 1 to 863       863/863
(100 %)
2 diff
(99.8 %id)
CB139642 Liver .a 129 to 547 1 to 419       419/419
(100 %)
5 diff
(98.9 %id)
CR624496 Placenta Cot 25-normalized .a 131 to 1541 1 to 1411 exact     1411/1411
(100 %)
0 diff
(100 %id)
BX358206 Placenta Cot 25-normalized .a 131 to 1159 1 to 1016       1016/1016
(100 %)
15 diff
(98.6 %id)
BX402439 Placenta Cot 25-normalized .a 131 to 1154 1 to 1017       1017/1023
(99 %)
8 diff
(99.3 %id)
BQ427936 leiomyosarcoma, uterus .a 131 to 863 1 to 738       738/767
(96 %)
14 diff
(98.2 %id)
DR159480 human embryonic stem cells differentiated toan early endodermal cell type .a 132 to 857 1 to 723       723/723
(100 %)
2 diff
(99.8 %id)
CB111424 Liver .a 134 to 725 1 to 592       592/592
(100 %)
2 diff
(99.7 %id)
CB148624 Liver .a 134 to 576 1 to 443       443/443
(100 %)
1 diff
(99.8 %id)
DA605251   .a 135 to 453 2 to 320   capped   319/319
(100 %)
0 diff
(100 %id)
DA611625   .a 135 to 728 2 to 597   capped   596/596
(100 %)
2 diff
(99.7 %id)
DA615916   .a 135 to 705 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
BI858730 breast, mammary adenocarcinoma, cell line .a 137 to 826 12 to 700       689/700
(98 %)
7 diff
(99.0 %id)
TI_57189062   .a 137 to 826 97 to 785       689/701
(98 %)
7 diff
(99.1 %id)
BE791442 lung, small cell carcinoma .a 139 to 875 1 to 735       735/736
(99 %)
4 diff
(99.5 %id)
BE790555 lung, small cell carcinoma .a 140 to 975 1 to 839       841/936
(89 %)
57 diff
(94.0 %id)
BI862616 breast, mammary adenocarcinoma, cell line .a 140 to 629 1 to 502       502/973
(51 %)
19 diff
(98.1 %id)
TI_57191958   .a 140 to 629 55 to 556       502/973
(51 %)
19 diff
(98.1 %id)
BU153921 eye, retinoblastoma .a 143 to 968 1 to 837       835/837
(99 %)
22 diff
(97.4 %id)
BU165059 eye, retinoblastoma .a 143 to 968 1 to 833       833/868
(95 %)
15 diff
(98.3 %id)
CX164331 human embryonic stem cells differentiated toan early endodermal cell type .a 144 to 979 1 to 836       836/836
(100 %)
0 diff
(100 %id)
DR155704 human embryonic stem cells differentiated toan early endodermal cell type .a 144 to 922 1 to 779       779/779
(100 %)
0 diff
(100 %id)
BU167453 eye, retinoblastoma .a 147 to 1027 1 to 894       894/928
(96 %)
44 diff
(95.3 %id)
BF688762 eye, normal pigmented retinal epithelium .a 149 to 932 1 to 782       784/951
(82 %)
20 diff
(97.9 %id)
BG471721 eye, retinoblastoma .a 149 to 924 1 to 791       791/791
(100 %)
24 diff
(97.0 %id)
BQ306348 breast .a 151 to 280 128 to 1       128/128
(100 %)
1 diff
(99.3 %id)
CN281385 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 151 to 666 1 to 516       516/516
(100 %)
1 diff
(99.9 %id)
BE255879 eye, retinoblastoma .a 160 to 749 1 to 592       592/592
(100 %)
2 diff
(99.7 %id)
BE794011 lung, small cell carcinoma .a 165 to 905 1 to 741       741/741
(100 %)
1 diff
(99.9 %id)
BE791284 lung, small cell carcinoma .a 168 to 993 1 to 814       816/955
(85 %)
31 diff
(96.8 %id)
BE538183 cervix .a 170 to 781 1 to 625       625/625
(100 %)
30 diff
(95.2 %id)
CN281373 embryonic stem cells, DMSO-treated H9 cellline .a 171 to 680 1 to 510       510/510
(100 %)
0 diff
(100 %id)
AF002822   .a 173 to 1555 1 to 1383 exact AAA   1383/1383
(100 %)
1 diff
(100.0 %id)
BU162221 leiomyosarcoma, uterus .a 174 to 956 1 to 783       783/783
(100 %)
6 diff
(99.3 %id)
DR762444 embryonic stem .a 175 to 1012 12 to 849       838/849
(98 %)
6 diff
(99.3 %id)
AA448945.
matches multiple genes
  .a 178 to 662 1 to 485     also hits gene NPM3 485/485
(100 %)
2 diff
(99.6 %id)
BF738329 bladder_tumor .a 188 to 377 1 to 191       191/192
(99 %)
8 diff
(95.9 %id)
R29074   .a 188 to 384 1 to 193       196/193
(101 %)
6 diff
(96.9 %id)
BT019458   .a 192 to 1388 1 to 1197 S150F R272L     1197/1197
(100 %)
3 diff
(99.8 %id)
CR533527   .a 192 to 1397 1 to 1206 exact     1206/1206
(100 %)
0 diff
(100 %id)
BF035970 adenocarcinoma, ovary .a 197 to 1031 1 to 832       832/930
(89 %)
60 diff
(93.6 %id)
AA296834 aorta .a 201 to 505 1 to 307       307/310
(99 %)
3 diff
(99.1 %id)
BG945956 bladder_tumor .a 215 to 377 16 to 175       160/194
(82 %)
11 diff
(94.4 %id)
BQ052069 blood, natural killer cells, cell line .a 215 to 1023 169 to 981       813/1126
(72 %)
29 diff
(97.5 %id)
BE889597 leiomyosarcoma, uterus .a 216 to 886 1 to 678       676/678
(99 %)
10 diff
(98.6 %id)
BI198274 brain, neuroblastoma .a 225 to 994 1 to 781       781/781
(100 %)
24 diff
(97.0 %id)
AA129846 uterus .a 282 to 803 1 to 525       525/525
(100 %)
10 diff
(98.1 %id)
BX102366 uterus .a 285 to 1025 1 to 741       741/741
(100 %)
0 diff
(100 %id)
BI858560 breast, mammary adenocarcinoma, cell line .a 291 to 1105 1 to 814       814/814
(100 %)
4 diff
(99.6 %id)
TI_57191481   .a 291 to 1105 93 to 906       814/814
(100 %)
4 diff
(99.6 %id)
DR156954 human embryonic stem cells differentiated toan early endodermal cell type .a 293 to 1048 1 to 756       756/756
(100 %)
6 diff
(99.3 %id)
DB127962 thymus .a 343 to 909 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
BG389947 embryonal carcinoma, cell line, testis .a 359 to 992 1 to 633       633/633
(100 %)
1 diff
(99.9 %id)
BE047883 brain, tumor, 5 pooled (see description) .a 362 to 950 1 to 589       589/589
(100 %)
0 diff
(100 %id)
TI_1241110701   .a 374 to 1420 1099 to 57     Submitted on the opposite strand 1043/1244
(83 %)
5 diff
(99.6 %id)
BU188677 bone marrow, from acute myelogenous leukemia .a 376 to 1166 1 to 798       796/810
(98 %)
18 diff
(97.8 %id)
BG120470 adenocarcinoma, cell line, Liver .a 391 to 993 1 to 602       604/602
(100 %)
5 diff
(99.2 %id)
AA127430 lung, lung carcinoma .a 409 to 836 1 to 429       429/429
(100 %)
1 diff
(99.8 %id)
CN281365 embryonic stem cells, DMSO-treated H9 cellline .a 411 to 1186 1 to 776       776/776
(100 %)
1 diff
(99.9 %id)
BQ439750 embryonal carcinoma, cell line, testis .a 413 to 1231 1 to 820       820/933
(87 %)
16 diff
(98.3 %id)
AA356440   .a 423 to 790 1 to 375       375/386
(97 %)
10 diff
(97.5 %id)
AW965782   .a 424 to 790 1 to 368       368/371
(99 %)
17 diff
(95.5 %id)
BM459148 melanotic melanoma, skin .a 435 to 1369 25 to 963       940/1036
(90 %)
16 diff
(98.5 %id)
TI_1241110709   .a 449 to 1427 1037 to 62       976/1213
(80 %)
9 diff
(99.3 %id)
BX358205 Placenta Cot 25-normalized .a 459 to 1527 1060 to 1       1060/1060
(100 %)
13 diff
(98.8 %id)
BX402438 Placenta Cot 25-normalized .a 459 to 1541 1075 to 1       1077/1076
(100 %)
15 diff
(98.7 %id)
BX402577 Placenta Cot 25-normalized .a 459 to 1519 1058 to 1       1058/1059
(99 %)
64 diff
(94.0 %id)
BM728898 eye, fetal eye .a 504 to 1095 1 to 593   fully sequenced,   593/593
(100 %)
1 diff
(99.9 %id)
BG105949 lymph, lymphoma, cell line .a 506 to 1260 1 to 764       764/845
(90 %)
19 diff
(97.8 %id)
CN281372 embryonic stem cells, DMSO-treated H9 cellline .a 513 to 1035 1 to 525       525/525
(100 %)
4 diff
(99.3 %id)
AL574578 placenta, Placenta Cot 25-normalized .a 523 to 1527 1002 to 5       998/1009
(98 %)
24 diff
(97.7 %id)
BE271635 adenocarcinoma cell line, ovary .a 528 to 1252 1 to 724       726/870
(83 %)
18 diff
(98.0 %id)
BX396826 Placenta Cot 25-normalized .a 549 to 1282 978 to 245       737/978
(75 %)
43 diff
(95.7 %id)
FN145140 breast carcinoma .a 554 to 648 1 to 92       92/93
(98 %)
2 diff
(97.9 %id)
BF744405 breast .a 556 to 841 1 to 286       286/286
(100 %)
0 diff
(100 %id)
BU941030 mixed (pool of 40 RNAs) .a 557 to 1359 1 to 816       814/816
(99 %)
22 diff
(97.4 %id)
TI_1241111545   .a 570 to 1420 1 to 855       851/1249
(68 %)
9 diff
(99.3 %id)
BE081899 breast .a 576 to 841 1 to 278       256/278
(92 %)
12 diff
(95.7 %id)
BE872474 adenocarcinoma, colon .a 628 to 1162 122 to 649       528/778
(67 %)
25 diff
(96.8 %id)
BU543077 carcinoma, cell line, Prostate .a 628 to 1407 1 to 785       785/946
(82 %)
9 diff
(99.1 %id)
TI_149309610   .a 629 to 1548 994 to 87   AAA   908/1001
(90 %)
29 diff
(97.2 %id)
BG105528 adrenal cortex carcinoma, cell line, adrenal gland .a 634 to 1439 9 to 801       793/892
(88 %)
31 diff
(96.6 %id)
BG105664 adrenal cortex carcinoma, cell line, adrenal gland .a 634 to 1399 8 to 775       768/958
(80 %)
25 diff
(97.4 %id)
BG034770 adenocarcinoma, cell line, Liver .a 636 to 1381 1 to 732       732/947
(77 %)
22 diff
(97.7 %id)
CN281375 embryonic stem cells, cell lines H1, H7, andH9 .a 647 to 1364 1 to 718       718/718
(100 %)
3 diff
(99.6 %id)
BE738611 brain, glioblastoma .a 692 to 1503 814 to 1       814/847
(96 %)
23 diff
(97.3 %id)
BX375983 Neuroblastoma Cot 25-normalized .a 694 to 1518 824 to 1   fully sequenced,   824/824
(100 %)
7 diff
(99.2 %id)
BE122764 skin .a 713 to 1460 1 to 748       748/748
(100 %)
0 diff
(100 %id)
BM802215 duodenal adenocarcinoma, cell line, small intestine .a 733 to 1518 10 to 812       803/868
(92 %)
28 diff
(96.8 %id)
CN281368 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 758 to 1372 17 to 633       617/633
(97 %)
10 diff
(98.5 %id)
BX354142 Neuroblastoma Cot 25-normalized .a 758 to 1519 762 to 1   fully sequenced,   762/762
(100 %)
1 diff
(99.9 %id)
AL565267 brain, fetal brain .a 758 to 1502 747 to 1   fully sequenced,   747/747
(100 %)
14 diff
(98.2 %id)
CB124168 Liver .a 768 to 1257 1 to 490       490/490
(100 %)
0 diff
(100 %id)
BJ994404 hepatoblastoma .a 774 to 1231 1 to 458   fully sequenced,   458/458
(100 %)
0 diff
(100 %id)
TI_159705467   .a 785 to 1555 795 to 35   AAA   761/967
(78 %)
16 diff
(98.4 %id)
CB528965 Aveolar Macrophage, lung .a 813 to 1555 761 to 19   AAA   743/743
(100 %)
3 diff
(99.6 %id)
AA522505 lung, lung tumor .a 818 to 1556 736 to 1       736/917
(80 %)
23 diff
(97.5 %id)
BF971007 adrenal cortex carcinoma, cell line, adrenal gland .a 827 to 1556 1 to 725       725/903
(80 %)
10 diff
(98.9 %id)
AI026942   .a 840 to 1556 721 to 3       719/721
(99 %)
9 diff
(98.8 %id)
AI148662 placenta .a 840 to 1556 723 to 8       716/723
(99 %)
3 diff
(99.6 %id)
AI223319 pooled .a 840 to 1556 718 to 3       716/718
(99 %)
5 diff
(99.4 %id)
AI566711 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 840 to 1556 718 to 6       713/718
(99 %)
14 diff
(98.1 %id)
W86021 liver and spleen .a 842 to 950 1 to 109       109/109
(100 %)
0 diff
(100 %id)
AI885254 anaplastic oligodendroglioma, brain .a 845 to 1555 711 to 1       711/716
(99 %)
7 diff
(99.1 %id)
AI589694 anaplastic oligodendroglioma, brain .a 851 to 1550 698 to 1       698/698
(100 %)
11 diff
(98.5 %id)
BU533550 mixed (pool of 40 RNAs) .a 853 to 1547 1 to 696       696/700
(99 %)
3 diff
(99.6 %id)
AW373217 breast .a 858 to 1315 458 to 2       457/458
(99 %)
3 diff
(99.4 %id)
BE079491 breast .a 858 to 1089 1 to 232       232/232
(100 %)
1 diff
(99.6 %id)
BF744406 breast .a 858 to 1029 1 to 172       172/172
(100 %)
0 diff
(100 %id)
BF816838 colon_ins .a 858 to 1308 1 to 451       451/451
(100 %)
1 diff
(99.8 %id)
BU616777 Cell Line, Chondrosarcoma .a 867 to 1555 703 to 19   AAA   685/687
(99 %)
4 diff
(99.5 %id)
BE082260 breast .a 873 to 1201 336 to 6     Submitted on the opposite strand 331/336
(98 %)
3 diff
(99.2 %id)
CN281369 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 879 to 1495 1 to 617       617/617
(100 %)
0 diff
(100 %id)
FN125355 breast carcinoma .a 881 to 995 1 to 112       112/112
(100 %)
6 diff
(94.7 %id)
TI_154132279   .a 885 to 1550 778 to 113   AAA   666/667
(99 %)
1 diff
(99.9 %id)
BU687991 lung .a 887 to 1548 680 to 19   AAA   662/662
(100 %)
2 diff
(99.7 %id)
CA423609 cell lines, Chondrosarcoma .a 893 to 1550 675 to 19   AAA   657/658
(99 %)
1 diff
(99.9 %id)
CA430530 Cell Line, Chondrosarcoma .a 895 to 1555 679 to 19   AAA   661/661
(100 %)
3 diff
(99.6 %id)
BF815352 colon_ins .a 896 to 1308 413 to 1     Submitted on the opposite strand 413/413
(100 %)
4 diff
(99.1 %id)
BQ775812 Bone, Human Chondrosarcoma Cell Line .a 896 to 1555 678 to 19   AAA   660/660
(100 %)
2 diff
(99.7 %id)
CA422966 cell lines, Chondrosarcoma .a 897 to 1555 678 to 19   AAA   660/660
(100 %)
1 diff
(99.9 %id)
BX374537 Neuroblastoma Cot 10-normalized .a 903 to 1552 1 to 650       650/650
(100 %)
0 diff
(100 %id)
CA430482 Cell Line, Chondrosarcoma .a 914 to 1555 660 to 19   AAA   642/642
(100 %)
0 diff
(100 %id)
AW169180 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 921 to 1552 633 to 5       629/633
(99 %)
4 diff
(99.4 %id)
CB127936 cervix, Uterine .a 953 to 1543 1 to 591       591/591
(100 %)
1 diff
(99.9 %id)
AW467305 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood .a 961 to 1552 592 to 1       592/593
(99 %)
15 diff
(97.5 %id)
AW574879 lymph .a 963 to 1550 605 to 18   AAA   588/588
(100 %)
0 diff
(100 %id)
BQ300484 bladder_tumor .a 971 to 1308 339 to 1       339/339
(100 %)
4 diff
(98.9 %id)
AA548534 adrenal adenoma, adrenal gland .a 973 to 1553 579 to 1       579/580
(99 %)
6 diff
(99.0 %id)
TI_1241111507   .a 974 to 1420 13 to 461       449/1180
(38 %)
7 diff
(99.5 %id)
AI209160 placenta .a 987 to 1554 568 to 1       568/568
(100 %)
5 diff
(99.2 %id)
AW264460 brain, three pooled meningiomas .a 990 to 1556 588 to 22       567/588
(96 %)
5 diff
(99.2 %id)
AI863120 brain, tumor, 5 pooled (see description) .a 993 to 1552 560 to 1       560/560
(100 %)
1 diff
(99.9 %id)
AI827718 pooled .a 993 to 1547 569 to 15   AAA   555/555
(100 %)
2 diff
(99.7 %id)
BF436072 pooled .a 993 to 1556 568 to 5       564/568
(99 %)
0 diff
(100 %id)
AI924812 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 994 to 1556 563 to 1       563/564
(99 %)
1 diff
(99.9 %id)
AW264424 brain, three pooled meningiomas .a 999 to 1555 579 to 23   AAA   557/563
(98 %)
56 diff
(90.1 %id)
AW197450 pooled germ cell tumors .a 1009 to 1555 547 to 1       547/548
(99 %)
1 diff
(99.9 %id)
BI260155 cervical carcinoma cell line, cervix .a 1011 to 1555 1 to 545   AAA   545/545
(100 %)
0 diff
(100 %id)
AA830281 germinal center B cell .a 1014 to 1556 551 to 9       543/551
(98 %)
4 diff
(99.3 %id)
DN915402   .a 1024 to 1524 501 to 2       500/503
(99 %)
1 diff
(99.9 %id)
AU144950 whole embryo, mainly head .a 1024 to 1555 532 to 1       532/544
(97 %)
14 diff
(97.5 %id)
AU160185   .a 1024 to 1555 531 to 1       531/543
(97 %)
8 diff
(98.6 %id)
AU160627   .a 1024 to 1555 533 to 1       533/556
(95 %)
3 diff
(99.5 %id)
AI827510 pooled .a 1025 to 1552 534 to 6       529/539
(98 %)
1 diff
(99.9 %id)
AA171505   .a 1035 to 1550 517 to 1       517/517
(100 %)
2 diff
(99.7 %id)
AA992158   .a 1035 to 1556 524 to 3       522/524
(99 %)
4 diff
(99.3 %id)
AW662743 pooled .a 1038 to 1556 521 to 3       519/521
(99 %)
0 diff
(100 %id)
AI630285 blood .a 1039 to 1460 422 to 1       422/422
(100 %)
1 diff
(99.8 %id)
BQ300568 bladder_tumor .a 1043 to 1308 266 to 1       266/266
(100 %)
0 diff
(100 %id)
BI859123 breast, mammary adenocarcinoma, cell line .a 1045 to 1555 1 to 512   AAA   512/512
(100 %)
1 diff
(99.9 %id)
TI_57188082   .a 1045 to 1555 49 to 560   AAA   512/512
(100 %)
1 diff
(99.9 %id)
AA477855 ovarian tumor, ovary .a 1056 to 1556 502 to 2     Submitted on the opposite strand 501/502
(99 %)
0 diff
(100 %id)
DW464537 Liver .a 1064 to 1150 17 to 103       87/103
(84 %)
6 diff
(94.2 %id)
AI916064 colon, colon tumor, RER+ .a 1065 to 1556 497 to 6       492/497
(98 %)
0 diff
(100 %id)
AW002272 thymus, pooled .a 1065 to 1556 491 to 2       490/491
(99 %)
11 diff
(97.8 %id)
N87720   .a 1065 to 1375 1 to 300       300/306
(98 %)
16 diff
(94.8 %id)
BU742917 eye, fetal eye .a 1065 to 1550 504 to 19   fully sequenced, AAA   486/486
(100 %)
0 diff
(100 %id)
AA774665   .a 1068 to 1556 492 to 4       489/492
(99 %)
8 diff
(98.4 %id)
AI283511 pooled .a 1072 to 1552 486 to 6       481/487
(98 %)
5 diff
(99.0 %id)
DB524947 testis .a 1082 to 1554 1 to 473     Submitted on the opposite strand 473/474
(99 %)
1 diff
(99.8 %id)
AI151355 placenta .a 1083 to 1556 480 to 8       473/480
(98 %)
3 diff
(99.4 %id)
AI285079 adenocarcinoma, colon .a 1083 to 1555 473 to 1       473/473
(100 %)
5 diff
(99.0 %id)
AU150057   .a 1084 to 1552 473 to 6       468/475
(98 %)
2 diff
(99.6 %id)
DB374854 placenta .a 1086 to 1546 462 to 4       459/570
(80 %)
7 diff
(98.8 %id)
AA707003 liver and spleen .a 1089 to 1555 467 to 1       467/467
(100 %)
3 diff
(99.4 %id)
AA812053 germinal center B cell .a 1092 to 1551 473 to 14       460/473
(97 %)
1 diff
(99.8 %id)
TI_154022132   .a 1096 to 1555 529 to 71   AAA   459/1119
(41 %)
1 diff
(100.0 %id)
CA438830 lung, Metastatic Chondrosarcoma .a 1096 to 1555 477 to 19   AAA   459/467
(98 %)
1 diff
(99.8 %id)
BE502584 pooled germ cell tumors .a 1100 to 1551 452 to 1       452/452
(100 %)
0 diff
(100 %id)
EC517957 Prostate .a 1105 to 1184 19 to 95       77/96
(80 %)
7 diff
(92.8 %id)
AW002394 pooled germ cell tumors .a 1107 to 1555 473 to 25   AAA   449/449
(100 %)
2 diff
(99.6 %id)
DB518403 testis .a 1110 to 1548 1 to 439     Submitted on the opposite strand 439/441
(99 %)
1 diff
(99.8 %id)
AA969143 pooled .a 1113 to 1380 268 to 1       268/268
(100 %)
8 diff
(97.1 %id)
AI932735 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 1113 to 1554 443 to 1       422/443
(95 %)
25 diff
(94.4 %id)
AA127431 lung, lung carcinoma .a 1114 to 1423 314 to 1       314/315
(99 %)
8 diff
(97.5 %id)
DB513544 testis .a 1128 to 1554 1 to 427     Submitted on the opposite strand 427/428
(99 %)
8 diff
(98.2 %id)
W86050 liver and spleen .a 1131 to 1547 426 to 6       421/426
(98 %)
4 diff
(99.1 %id)
AI538607 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 1140 to 1556 421 to 5       417/421
(99 %)
0 diff
(100 %id)
AA033883 heart .a 1141 to 1346 15 to 220   fully sequenced,   206/220
(93 %)
5 diff
(97.8 %id)
BF223506 pooled germ cell tumors .a 1152 to 1548 397 to 2       396/397
(99 %)
2 diff
(99.5 %id)
AI214873   .a 1155 to 1556 404 to 4       401/404
(99 %)
5 diff
(98.8 %id)
AW105471 ovary, tumor, 5 pooled (see description) .a 1156 to 1555 400 to 1       400/400
(100 %)
0 diff
(100 %id)
AA644331 lung, lung carcinoma .a 1158 to 1556 401 to 3       399/401
(99 %)
0 diff
(100 %id)
BG200046   .a 1163 to 1555 1 to 395   AAA   395/395
(100 %)
9 diff
(97.8 %id)
BG205738   .a 1163 to 1550 1 to 391   AAA   391/391
(100 %)
7 diff
(98.3 %id)
BG197426   .a 1165 to 1555 7 to 401   AAA   395/401
(98 %)
6 diff
(98.6 %id)
AI184396 placenta .a 1166 to 1554 384 to 1       384/423
(90 %)
15 diff
(96.5 %id)
AI886966 anaplastic oligodendroglioma, brain .a 1167 to 1552 388 to 3       386/388
(99 %)
3 diff
(99.3 %id)
N95207 lung .a 1168 to 1551 382 to 1       382/419
(91 %)
2 diff
(99.6 %id)
BQ436062 epithelioid carcinoma, Pancreas .a 1170 to 1550 1 to 381   AAA   381/381
(100 %)
0 diff
(100 %id)
AI274715 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 1177 to 1548 373 to 1       373/373
(100 %)
6 diff
(98.4 %id)
AI365259 pooled germ cell tumors .a 1179 to 1555 377 to 1       377/377
(100 %)
4 diff
(99.0 %id)
AI219971 pooled .a 1188 to 1552 366 to 2       365/366
(99 %)
1 diff
(99.8 %id)
DN918496   .a 1190 to 1554 365 to 2       364/365
(99 %)
0 diff
(100 %id)
AI696374 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 1200 to 1550 354 to 1       354/354
(100 %)
5 diff
(98.6 %id)
BJ994405 hepatoblastoma .a 1201 to 1520 320 to 1   fully sequenced,   320/320
(100 %)
0 diff
(100 %id)
BG575909 breast, mammary adenocarcinoma, cell line .a 1218 to 1555 1 to 338   AAA   338/338
(100 %)
0 diff
(100 %id)
BU532523 mixed (pool of 40 RNAs) .a 1230 to 1555 1 to 326       326/363
(89 %)
4 diff
(98.9 %id)
BQ276919 mixed (pool of 40 RNAs) .a 1241 to 1553 1 to 313   AAA   313/313
(100 %)
4 diff
(98.8 %id)
BM747499 stomach .a 1242 to 1548 1 to 307   AAA   307/307
(100 %)
0 diff
(100 %id)
AI184398 placenta .a 1252 to 1554 303 to 1       303/303
(100 %)
2 diff
(99.4 %id)
AW473393 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 1260 to 1383 124 to 1       124/124
(100 %)
4 diff
(96.8 %id)
AA129847 uterus .a 1278 to 1555 283 to 1       283/516
(54 %)
8 diff
(98.5 %id)
AA449672.
matches multiple genes
  .a 1278 to 1550 277 to 1     Submitted on the opposite strand, also hits gene ABTB1 277/319
(86 %)
6 diff
(98.2 %id)
AI873551 lymph node, lymphoma, follicular mixed small and largecell .a 1278 to 1556 278 to 1       278/318
(87 %)
2 diff
(99.4 %id)
AA621459   .a 1284 to 1380 97 to 1       97/97
(100 %)
1 diff
(99.0 %id)
AI886545 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 1284 to 1556 273 to 2       272/273
(99 %)
0 diff
(100 %id)
CB409706 maxilla, pooled .a 1287 to 1550 1 to 264   AAA   264/264
(100 %)
2 diff
(99.3 %id)
DB514844 testis .a 1295 to 1555 1 to 266     Submitted on the opposite strand 266/266
(100 %)
20 diff
(92.5 %id)
AA033826 heart .a 1316 to 1557 242 to 1   fully sequenced,   242/242
(100 %)
5 diff
(98.0 %id)
BE464149 pooled germ cell tumors .a 1322 to 1556 237 to 3       235/237
(99 %)
0 diff
(100 %id)
AA612786 colon, colon tumor RER+ .a 1375 to 1550 176 to 1       176/178
(98 %)
0 diff
(100 %id)
EC550580 Prostate .a 1461 to 1552 1 to 91       91/98
(92 %)
2 diff
(98.0 %id)
AA427882   .a 1548 to 1969 1 to 422   tiling clone, Submitted on the opposite strand 422/422
(100 %)
2 diff
(99.6 %id)
AI377052   .a 1548 to 2028 1 to 481     Submitted on the opposite strand 481/481
(100 %)
3 diff
(99.4 %id)
AA434540   .a 1702 to 2204 503 to 1   tiling clone, Submitted on the opposite strand 503/503
(100 %)
2 diff
(99.7 %id)
BX097390   .a 1789 to 2203 415 to 1   tiling clone, Submitted on the opposite strand 415/415
(100 %)
0 diff
(100 %id)
CA487612   .b 1 to 1000 5 to 1017   tiling clone,   1015/1019
(99 %)
19 diff
(98.2 %id)
DB112398 thymus .b 921 to 1494 2 to 573   tiling clone, capped   572/572
(100 %)
1 diff
(99.9 %id)
AA429725   .b 1484 to 1968 1 to 485   tiling clone,   485/485
(100 %)
0 diff
(100 %id)
CB052133 leiomyosarcoma, soft tissue .b 1494 to 2090 1 to 597   tiling clone,   597/597
(100 %)
4 diff
(99.4 %id)
AW976389   .b 2097 to 2747 648 to 1   tiling clone, Submitted on the opposite strand 648/652
(99 %)
14 diff
(97.9 %id)
CB052132 leiomyosarcoma, soft tissue .b 2216 to 2749 586 to 53   tiling clone,   534/586
(91 %)
0 diff
(100 %id)
AW270163 pooled .b 2234 to 2748 515 to 1       515/515
(100 %)
3 diff
(99.5 %id)
AA972405 pooled .b 2323 to 2748 426 to 1       426/426
(100 %)
0 diff
(100 %id)
AA743366 germinal center B cell .b 2367 to 2749 390 to 9   tiling clone,   382/390
(97 %)
0 diff
(100 %id)
AI919279 pooled germ cell tumors .b 2392 to 2748 357 to 1       357/357
(100 %)
0 diff
(100 %id)
AA442763   .b 2471 to 2749 284 to 6       279/284
(98 %)
0 diff
(100 %id)
CR600767 Placenta Cot 25-normalized .c 1 to 1064 1 to 1064 exact tiling clone,   1064/1064
(100 %)
0 diff
(100 %id)
BF968701 adrenal cortex carcinoma, cell line, adrenal gland .d 1 to 740 1 to 740 G88A I89L M90W D91I R92D ... tiling clone,   740/740
(100 %)
7 diff
(99.1 %id)
AV712424   Gene CCNB2, variant not shown         Suspected internal deletion, this clone was ignored    
BP320634 placenta Gene CCNB2, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI